Current status:
Cancelled Post Market
Current status date:
2021-06-30
DIN:
02246971
Electronic product monograph is not available
Company:
PURDUE PHARMA
310
3381 Steeles Avenue East
Toronto
Ontario
Canada
M2H 3S7
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Anatomical Therapeutic Chemical (ATC):
See footnote 4
R05CA10 COMBINATIONS
List of active ingredient(s)
Active ingredient(s) |
Strength |
GUAIFENESIN
|
600 MG
|
PSEUDOEPHEDRINE HYDROCHLORIDE
|
120 MG
|